Notice for selinexor (Antengene (AUS) Pty Ltd)
Active ingredients
selinexor
Sponsor
Date of review outcome
Lapse date
Type
Orphan drug
Dosage form(s)
film-coated tablet
Indication
For the treatment of diffuse large B-Cell lymphoma
Therapeutic area
Haematology